Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 109

Similar articles for PubMed (Select 20621909)

1.

Menopausal hormone therapy and risk for cardiovascular disease in the WHI trial.

Harman SM, Brinton EA, Naftolin F, Merriam GR, Cedars MI, Freeman RG, Santoro N.

Ann Intern Med. 2010 Jul 6;153(1):60-1; author reply 61-2. doi: 10.7326/0003-4819-153-1-201007060-00019. No abstract available.

PMID:
20621909
2.

Menopausal hormone therapy and risk for cardiovascular disease in the WHI trial.

Pines A, Sturdee D.

Ann Intern Med. 2010 Jul 6;153(1):61; author reply 61-2. doi: 10.7326/0003-4819-153-1-201007060-00020. No abstract available.

PMID:
20621912
3.

Menopausal hormone therapy and risk for cardiovascular disease in the WHI trial.

Sullivan JL.

Ann Intern Med. 2010 Jul 6;153(1):61; author reply 61-2. doi: 10.7326/0003-4819-153-1-201007060-00021. No abstract available.

PMID:
20621911
4.

Women's health. The vanishing promises of hormone replacement.

Enserink M.

Science. 2002 Jul 19;297(5580):325-6. No abstract available.

PMID:
12130763
5.

Lung cancer and hormone replacement therapy.

Canonico M, Plu-Bureau G, Scarabin PY.

Lancet. 2010 Jan 9;375(9709):117; author reply 118-9. doi: 10.1016/S0140-6736(10)60039-6. No abstract available.

PMID:
20109882
6.

Re: Estrogen plus progestin therapy and breast cancer in recently postmenopausal women.

Langer RD.

Am J Epidemiol. 2009 Mar 15;169(6):784-5; author reply 785-6. doi: 10.1093/aje/kwn420. Epub 2009 Feb 10. No abstract available.

7.

Summaries for patients: The effect of estrogen plus progestin on coronary heart disease.

[No authors listed]

Ann Intern Med. 2010 Feb 16;152(4):I-40. doi: 10.7326/0003-4819-152-4-201002160-00002. No abstract available.

PMID:
20157120
8.

A clinician's review of the WHI-related literature.

Speroff L.

Int J Fertil Womens Med. 2004 Nov-Dec;49(6):252-67. Review.

PMID:
15751264
9.

HRT Reconsidered: What should you tell patients about it now?

Aschenbrenner DS.

Am J Nurs. 2004 Jun;104(6):51-3. Review. No abstract available.

PMID:
15187613
10.

[Postmenopausal hormone therapy after WHI and HERS].

Birkhäuser M, de Geyter C, Keller PJ, Luzuy F.

Gynakol Geburtshilfliche Rundsch. 2004 Oct;44(4):244-8. German. No abstract available.

PMID:
15459524
11.

The SOGC statement on the WHI report on estrogen and progestin use in postmenopausal women.

Blake JM, Collins JA, Reid RL, Fedorkow DM, Lalonde AB, Christilaw J, Fortier M, Fortin C, Jolly EE, Lemay A, O'Grady T, Smith TE, Cooper J, Maxted JM, O'Grady K, Turek MA; SOGC (Society of Obstetricians and Gynaecologists of Canada).

J Obstet Gynaecol Can. 2002 Oct;24(10):783-90, 793-802. English, French.

PMID:
12399806
12.

[Postmenopausal hormone replacement therapy and cardiovascular risk: role of conjugated equine estrogens and medroxyprogesterone acetate].

Ortmann J, Traupe T, Vetter W, Barton M.

Praxis (Bern 1994). 2004 May 19;93(21):904-14. Review. German.

PMID:
15216975
13.
15.

The WHI ten year's later: an epidemiologist's view.

Lacey JV Jr.

J Steroid Biochem Mol Biol. 2014 Jul;142:12-5. doi: 10.1016/j.jsbmb.2013.08.006. Epub 2013 Sep 9. Review.

PMID:
24029430
16.

Discussing breast cancer and hormone replacement therapy with women.

Batur P, Thacker HL, Moore HC.

Cleve Clin J Med. 2002 Nov;69(11):838, 840, 843-4 passim.

PMID:
12430969
17.

NIH workshop tries to create consensus on HRT use.

Randal J.

J Natl Cancer Inst. 2003 Jan 1;95(1):9-11. No abstract available.

18.

New information about hormone therapy and cardiovascular disease prevention in women.

Goldie MP.

Int J Dent Hyg. 2007 Aug;5(3):190-3. No abstract available.

PMID:
17615030
19.

Post-menopausal hormone replacement therapy (cont'd): risk-benefit balance in the hot seat.

[No authors listed]

Prescrire Int. 2004 Jun;13(71):106-9.

PMID:
15233153
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk